At-Home Cervical Cancer Screening: FDA Approval
- The Teal Wand offers a convenient, private option that could encourage more women to get tested, leading to earlier detection and treatment.
- The Food and Drug Management (FDA) has approved the Teal Wand, a novel self-collection device for HPV testing, offering a new avenue for cervical cancer screening.
- Cervical cancer screening is crucial for early detection, often identifying precancerous changes.
Get the facts: The FDA has approved the Teal Wand, an at-home HPV test, revolutionizing cervical cancer screening. This self-collection device bypasses the need for a speculum exam, offering a convenient and private choice.By removing barriers to testing, such as lack of transportation, this could boost screening rates and lead to earlier detection.Learn how this innovative test works, and discover its limitations on the News Directory 3 site. Discover what’s next for at-home cervical cancer screenings.
FDA Approves Teal Wand for At-Home HPV Testing, Boosting Cervical Cancer Screening
Updated May 25, 2025
The Food and Drug Management (FDA) has approved the Teal Wand, a novel self-collection device for HPV testing, offering a new avenue for cervical cancer screening. This at-home HPV test eliminates the need for a speculum exam or a visit to a doctor’s office, allowing individuals to collect their own samples and mail them to a lab for analysis.
Cervical cancer screening is crucial for early detection, often identifying precancerous changes. However, screening rates have been declining, prompting experts to explore accessible alternatives like at-home tests. The Teal Wand aims to address barriers such as discomfort, lack of transportation, and time constraints.
The Teal Wand features a handle, a sponge at the top, and a dial to spin the sponge for sample collection. Users insert the wand into the vagina until slight resistance is felt, spin the sponge, detach it, and send it to a lab. A SELF-CERV study showed that over 98% of participants collected a valid sample, with 95% agreement with clinician-collected samples. Additionally, 93% found the device easy to use, and 94% preferred it over clinician collection.
“Hopefully, being allowed to swab ourselves at home will cast a wider screening net that includes people who lack transportation, can’t take time off, or put off speculum exams because they find them too uncomfortable.”
What’s next
Teal Health plans to launch the Teal Wand in California in June 2025, with hopes of expanding distribution to other states. A prescription is required, and the company will offer a telehealth option. The at-home HPV test is not recommended for those who are pregnant, have a history of cervical precancer treatment, are HIV-positive, immunosuppressed, or have a history of reproductive system cancer.